Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Paul Pickering, Atul Butte, David Altshuler, More

Premium

Maverix Biomics has appointed Paul Pickering as COO. Pickering joins Maverix from Life Technologies where he was most recently general manager and head of the Digital PCR Business Unit.

At Maverix, he will manage business functions related to the company's cloud-based analytic platform for next-generation sequencing data.

He holds a master's degree in biochemical engineering from the University of Birmingham, a PhD in biochemical engineering from the University of Bath, and an MBA from Harvard Business School.


The Obama Administration has awarded 13 scientists the Open Science Champions of Change honor, including seven genomic and molecular scientists, Atul Butte, David Altshuler, David Lipman, Drew Endy, John Quackenbush, Kathy Giusti, and Stephen Friend.


Genome Quebec has added three new members to its board of directors, including Christiane Ayotte, Egidio Nascimento, and Jacques Simoneau, while two members, Monique Letourneau and Raymond Langlois, have left the board.

Nascimento is CFO at Variation Biotechnologies, and he has previously served as VP of finance for Genome Canada.

Ayotte is a professor and director of the Doping Control Laboratory at Quebec's INRS Institute.

Simoneau is president and CEO at Gestion Univalor, and he previously held management positions in venture capital and investing at the Solidarity
Fund and the Business Development Bank of Canada.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.